Skip to main content
VCbacked
Log inGet Started

South Rampart Pharma

New Orleans, United States

South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.

$8.0M raised
May 2025
Series A
Health CareLife SciencePharmaceutical

Top Investors

National Institutes of HealthOchsner Health SystemGulf South Angels

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about South Rampart Pharma

How much funding has South Rampart Pharma raised?
South Rampart Pharma has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Who are South Rampart Pharma's investors?
South Rampart Pharma's investors include National Institutes of Health, Ochsner Health System, Gulf South Angels.
Where is South Rampart Pharma headquartered?
South Rampart Pharma is headquartered in New Orleans, United States.
What does South Rampart Pharma do?
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
What stage is South Rampart Pharma at?
South Rampart Pharma is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"South Rampart Pharma — Funding & Investors." VCBacked, May 21, 2025, https://www.vcbacked.co/company/south-rampart-pharma. Accessed June 4, 2026.
APA
VCBacked. (2025). South Rampart Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/south-rampart-pharma
Wikipedia (cite web)
{{cite web |title=South Rampart Pharma — Funding & Investors |url=https://www.vcbacked.co/company/south-rampart-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K